Cough syrup controversy: Segment sees a “cautious” shift by consumers and doctors, say industry -watchers

Cough syrup sales shift cautiously towards established brands amid controversy, impacting consumer and doctor preferences, ...
Reuters

CORRECTED-UPDATE 3-Indian court grants Pfizer stay on ban of popular cough syrup

MUMBAI/NEW DELHI, March 14 (Reuters) - An Indian court granted U.S. pharmaceuticals firm Pfizer Inc's Indian unit a stay order on Monday, pending a further hearing, on a government ban on its popular ...
Businessworld

Delhi High Court Grants Pfizer Temporary Relief On Cough Syrup Ban

Delhi High Court granted US drugmaker Pfizer an interim injunction on a ban on its popular cough syrup Corex, days after the government ordered it to be prohibited citing a potential risk to humans.
Reuters

Indian court stays government ban on Pfizer's Corex cough syrup - TV

MUMBAI, March 14 (Reuters) - An Indian court on Monday granted U.S. pharmaceuticals giant Pfizer Inc's India unit a stay on a government ban on its popular cough syrup Corex, local television channels ...